Myriad Genetics buy Guggenheim
Start price
14.12.23
/
50%
€19.70
Target price
14.12.24
€21.01
Performance (%)
-6.09%
Price
02.05.24
€18.10
Summary
This prediction is currently active. With a performance of -6.09%, the BUY prediction for Myriad Genetics by Guggenheim is down slightly. This prediction currently runs until 14.12.24. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | 9.697% | 9.697% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Guggenheim for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for MYGN provided by MarketBeat